Tuesday, 17 November 2026 Every SEC filing alert, by company
ALFA USA Filings Every alert, straight from SEC EDGAR
News

Nurix Therapeutics, Inc.

NASDAQ: NRIX · Life Sciences · 11 alerts · CIK 1549595

Share price
$14.73Close, Nov 16
Market cap
$1.61B
Shares outstanding
109.25MLatest SEC cover page
Sector
Life Sciences
Industry
Pharmaceutical PreparationsSIC 2834

Today's reference numbers: shares from the company's latest SEC cover page, price from the latest market close. Not a valuation or a recommendation. All Nurix Therapeutics, Inc. filings on SEC EDGAR ↗

5:06 PM ET Form 4
Insider Selling

Nurix Therapeutics CFO Houte Hans van Sells $74.6K of Stock

Houte Hans van, CFO, sold 4,769 shares of Nurix Therapeutics, Inc. at $15.38 to $16.20 a share (average $15.63) in 2 transactions, worth $74.6K in total on Nov 4, 2026. Shares held after the trade: 42,745 (-3.3%).

Value
$74.6K
Shares
4,769
Average price
$15.63
Role
CFO
Holding change
-3.3%
Trade date
Nov 4, 2026
5:03 PM ET Form 4
Insider Selling

Nurix Therapeutics CLO Christine Ring Sells $432K of Stock

Christine Ring, CLO, sold 16,715 shares of Nurix Therapeutics, Inc. at $25.74 to $26.76 a share (average $25.84) in 3 transactions, worth $432K in total between Nov 2, 2026 and Nov 3, 2026. Shares held after the trade: 4,406 (-58.1%).

Value
$432K
Shares
16,715
Average price
$25.84
Role
CLO
Holding change
-58.1%
Trade date
Nov 2, 2026 to Nov 3, 2026
7:47 PM ET Form 4
Insider Selling

Nurix Therapeutics CFO Houte Hans van Sells $74.5K of Stock

Houte Hans van, CFO, sold 2,834 shares of Nurix Therapeutics, Inc. at $26.28 a share, worth $74.5K in total on Oct 30, 2026. Shares held after the trade: 47,514 (-5.6%).

Value
$74.5K
Shares
2,834
Price
$26.28
Role
CFO
Holding change
-5.6%
Trade date
Oct 30, 2026
7:45 PM ET Form 4
Insider Selling

Nurix Therapeutics CLO Christine Ring Sells $104K of Stock

Christine Ring, CLO, sold 3,957 shares of Nurix Therapeutics, Inc. at $26.28 a share, worth $104K in total on Oct 30, 2026. Shares held after the trade: 15,335 (-20.5%).

Value
$104K
Shares
3,957
Price
$26.28
Role
CLO
Holding change
-20.5%
Trade date
Oct 30, 2026
7:42 PM ET Form 4
Insider Selling

Nurix Therapeutics CSO Gwenn Hansen Sells $143K of Stock

Gwenn Hansen, CSO, sold 5,409 shares of Nurix Therapeutics, Inc. at $26.28 to $26.80 a share (average $26.42) in 2 transactions, worth $143K in total between Oct 30, 2026 and Nov 2, 2026. Shares held after the trade: 123,452 (-1.2%).

Value
$143K
Shares
5,409
Average price
$26.42
Role
CSO
Holding change
-1.2%
Trade date
Oct 30, 2026 to Nov 2, 2026
5:00 PM ET Form 4
Insider Selling

Nurix Therapeutics CSO Gwenn Hansen Sells $36.3K of Stock

Gwenn Hansen, CSO, sold 1,452 shares of Nurix Therapeutics, Inc. at $25.00 a share, worth $36.3K in total on Oct 15, 2026. Shares held after the trade: 117,227 (-1.2%).

Value
$36.3K
Shares
1,452
Price
$25.00
Role
CSO
Holding change
-1.2%
Trade date
Oct 15, 2026
4:12 PM ET Form 4
Insider Selling

Nurix Therapeutics Insider Julia P. Gregory Sells $529K of Stock

Julia P. Gregory sold 22,583 shares of Nurix Therapeutics, Inc. at $23.40 a share, worth $529K in total on Oct 14, 2026. Shares held after the trade: 10,750 (-67.7%).

Value
$529K
Shares
22,583
Price
$23.40
Holding change
-67.7%
Trade date
Oct 14, 2026
5:21 PM ET Form 4
Insider Selling

Nurix Therapeutics CLO Christine Ring Sells $134K of Stock

Christine Ring, CLO, sold 5,786 shares of Nurix Therapeutics, Inc. at $23.19 a share, worth $134K in total on Oct 2, 2026. Shares held after the trade: 9,110 (-38.8%).

Value
$134K
Shares
5,786
Price
$23.19
Role
CLO
Holding change
-38.8%
Trade date
Oct 2, 2026

Get Alerts

Get ALFA Finder alerts first

Real-time SEC filing alerts for US stocks are launching soon. Leave your details and we'll tell you the moment they go live.